[go: up one dir, main page]

FI20085807A0 - Förfarande för tillverkning av escitalopram - Google Patents

Förfarande för tillverkning av escitalopram

Info

Publication number
FI20085807A0
FI20085807A0 FI20085807A FI20085807A FI20085807A0 FI 20085807 A0 FI20085807 A0 FI 20085807A0 FI 20085807 A FI20085807 A FI 20085807A FI 20085807 A FI20085807 A FI 20085807A FI 20085807 A0 FI20085807 A0 FI 20085807A0
Authority
FI
Finland
Prior art keywords
escitalopram
preparation
Prior art date
Application number
FI20085807A
Other languages
English (en)
Finnish (fi)
Other versions
FI121570B (sv
FI20085807L (sv
Inventor
Carla Defaveri
Florian Anton Martin Huber
Robert Dancer
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39735675&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI20085807(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of FI20085807A0 publication Critical patent/FI20085807A0/sv
Publication of FI20085807L publication Critical patent/FI20085807L/sv
Application granted granted Critical
Publication of FI121570B publication Critical patent/FI121570B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/32—Separation; Purification; Stabilisation; Use of additives
    • C07C253/34—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/53—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and hydroxy groups bound to the carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI20085807A 2007-09-11 2008-08-29 Förfarande för tillverkning av escitalopram FI121570B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK200701314 2007-09-11
DKPA200701314 2007-09-11

Publications (3)

Publication Number Publication Date
FI20085807A0 true FI20085807A0 (sv) 2008-08-29
FI20085807L FI20085807L (sv) 2009-03-12
FI121570B FI121570B (sv) 2011-01-14

Family

ID=39735675

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20085807A FI121570B (sv) 2007-09-11 2008-08-29 Förfarande för tillverkning av escitalopram

Country Status (52)

Country Link
EP (2) EP2397461A1 (sv)
JP (1) JP4966933B2 (sv)
KR (1) KR101054224B1 (sv)
CN (1) CN101386583A (sv)
AR (2) AR068174A1 (sv)
AT (2) ATE518829T1 (sv)
AU (1) AU2008212055C1 (sv)
BE (1) BE1017548A6 (sv)
BG (1) BG110206A (sv)
BR (1) BRPI0804121B1 (sv)
CA (1) CA2638499C (sv)
CH (1) CH697885B1 (sv)
CL (1) CL2008002686A1 (sv)
CO (1) CO6140012A1 (sv)
CY (2) CY2600B1 (sv)
CZ (1) CZ2008537A3 (sv)
DE (1) DE102008046530A1 (sv)
DK (2) DK2061753T3 (sv)
EA (1) EA012787B1 (sv)
EE (1) EE00864U1 (sv)
ES (2) ES2334875B1 (sv)
FI (1) FI121570B (sv)
FR (1) FR2920766A1 (sv)
GB (1) GB2448848B (sv)
GR (1) GR1006595B (sv)
HR (2) HRP20080425A2 (sv)
HU (1) HUP0800549A2 (sv)
IE (1) IES20080708A2 (sv)
IL (1) IL193845A (sv)
IS (1) IS8758A (sv)
LT (1) LT5577B (sv)
LU (1) LU91479B1 (sv)
LV (1) LV13813B (sv)
ME (1) ME00176B (sv)
MX (1) MX2008011451A (sv)
MY (1) MY144210A (sv)
NL (1) NL2001953C2 (sv)
NO (1) NO20083756L (sv)
NZ (1) NZ570884A (sv)
PL (2) PL386026A1 (sv)
PT (2) PT104169A (sv)
RO (1) RO125301A2 (sv)
RS (2) RS20080401A (sv)
SE (1) SE533041C2 (sv)
SG (1) SG151195A1 (sv)
SI (2) SI22567A2 (sv)
SK (1) SK500302008A3 (sv)
TR (2) TR200806903A2 (sv)
TW (1) TWI391383B (sv)
UA (2) UA41919U (sv)
WO (1) WO2009033488A1 (sv)
ZA (1) ZA200807753B (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1987016A1 (en) 2005-07-27 2008-11-05 Aurobindo Pharma Limited An improved process for the preparation of escitalopram
CN102796065A (zh) * 2011-05-27 2012-11-28 江苏豪森医药集团连云港宏创医药有限公司 一种制备光学纯度高的艾司西酞普兰的方法
CN104119240A (zh) * 2013-04-23 2014-10-29 中国人民解放军军事医学科学院毒物药物研究所 (S)-(-)-α-甲胺基苯丙酮的制备方法
CN103497145B (zh) * 2013-10-10 2016-01-27 南昌大学 一种光学纯多奈哌齐的制备工艺
CN104119248A (zh) * 2014-08-08 2014-10-29 广东东阳光药业有限公司 S-西酞普兰的制备方法
EP3219702B1 (en) * 2014-11-14 2021-05-05 Zhejiang Huahai Pharmaceuticals Co., Ltd. Method for resolution of citalopram intermediate 5-cyanogen diol

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
AR034612A1 (es) 2001-06-25 2004-03-03 Lundbeck & Co As H Proceso para la preparacion del citalopram racemico y/o del s- o r-citalopram mediante la separacion de una mezcla de r- y s-citalopram
AR034759A1 (es) * 2001-07-13 2004-03-17 Lundbeck & Co As H Metodo para la preparacion de escitalopram
IS7239A (is) * 2001-12-14 2004-04-29 H. Lundbeck A/S Aðferð til framleiðslu á essítalóprami
JP4505335B2 (ja) 2002-12-23 2010-07-21 ハー・ルンドベック・アクチエゼルスカベット ラセミ体シタロプラムジオール（ｒａｃｅｍｉｃｃｉｔａｌｏｐｒａｍｄｉｏｌ）および／またはＳ−もしくはＲ−シタロプラムジオールの製造方法、およびラセミ体シタロプラム、Ｒ−シタロプラムおよび／またはＳ−シタロプラムを製造するために、上記ジオールを使用する方法。
WO2004065375A1 (en) * 2003-01-17 2004-08-05 Natco Pharma Limited Processes for the preparation of escitalopram and its precursor
EP1706394B1 (en) * 2003-11-12 2014-12-17 Dr. Reddy's Laboratories, Inc. Preparation of escitalopram
EP1877394A1 (en) * 2005-04-04 2008-01-16 Jubilant Organosys Limited Process for the preparation of escitalopram or its acid addition salts
EP1987016A1 (en) * 2005-07-27 2008-11-05 Aurobindo Pharma Limited An improved process for the preparation of escitalopram

Also Published As

Publication number Publication date
AT10984U1 (de) 2010-02-15
EE00864U1 (et) 2009-10-15
TR200806903A2 (tr) 2009-03-23
GR1006595B (el) 2009-11-16
UA43461U (uk) 2009-08-25
PL386026A1 (pl) 2009-02-16
KR20090027185A (ko) 2009-03-16
ES2334875A1 (es) 2010-03-16
CH697885B1 (de) 2009-03-13
IL193845A (en) 2011-03-31
BRPI0804121A8 (pt) 2021-04-13
HU0800549D0 (en) 2008-10-28
RS20080401A (en) 2010-03-02
LT2008068A (en) 2009-03-25
RO125301A2 (ro) 2010-03-30
FI121570B (sv) 2011-01-14
SE0801929L (sv) 2009-03-12
BRPI0804121A2 (pt) 2009-09-29
DK177075B1 (da) 2011-06-14
BE1017548A6 (fr) 2008-11-04
DK200801265A (en) 2009-03-12
DE102008046530A1 (de) 2009-03-19
RS51909B (en) 2012-02-29
UA41919U (uk) 2009-06-10
FR2920766A1 (fr) 2009-03-13
KR101054224B1 (ko) 2011-08-08
CA2638499A1 (en) 2008-11-21
BG110206A (en) 2009-03-31
LT5577B (lt) 2009-06-25
GB2448848A (en) 2008-10-29
CA2638499C (en) 2010-09-28
PL2061753T3 (pl) 2011-12-30
BRPI0804121B1 (pt) 2022-04-12
SG151195A1 (en) 2009-04-30
CZ2008537A3 (cs) 2009-03-18
TWI391383B (zh) 2013-04-01
HUP0800549A2 (en) 2009-03-02
CY1111924T1 (el) 2015-11-04
SK500302008A3 (sk) 2009-04-06
CL2008002686A1 (es) 2009-01-02
HRP20110636T1 (hr) 2011-10-31
NL2001953A1 (nl) 2008-12-22
AR108885A2 (es) 2018-10-03
LU91479B1 (fr) 2010-03-11
ES2368294T3 (es) 2011-11-16
MEP10108A (bs) 2010-10-10
PT104169A (pt) 2009-02-02
ZA200807753B (en) 2009-04-29
GB2448848B (en) 2011-01-26
PT2061753E (pt) 2011-09-14
EA200801797A2 (ru) 2008-12-30
HRP20080425A2 (hr) 2010-04-30
EA012787B1 (ru) 2009-12-30
ME00176B (me) 2011-02-10
CO6140012A1 (es) 2010-03-19
JP2009149600A (ja) 2009-07-09
NZ570884A (en) 2010-03-26
SE533041C2 (sv) 2010-06-15
ATE518829T1 (de) 2011-08-15
AU2008212055B2 (en) 2010-08-12
NL2001953C2 (en) 2009-05-07
IES20080708A2 (en) 2009-03-18
GB0815773D0 (en) 2008-10-08
TW200906814A (en) 2009-02-16
EP2061753A1 (en) 2009-05-27
DK2061753T3 (da) 2011-09-26
IS8758A (is) 2009-03-12
AU2008212055C1 (en) 2011-06-02
EP2397461A1 (en) 2011-12-21
GR20080100581A (el) 2009-04-30
ES2334875B1 (es) 2010-10-27
AR068174A1 (es) 2009-11-11
AU2008212055A1 (en) 2009-03-26
CN101386583A (zh) 2009-03-18
EP2061753B1 (en) 2011-08-03
MY144210A (en) 2011-08-15
SI2061753T1 (sl) 2011-10-28
CY2600B1 (en) 2010-03-03
FI20085807L (sv) 2009-03-12
LV13813B (en) 2008-11-20
MX2008011451A (es) 2009-03-10
NO20083756L (no) 2009-03-12
WO2009033488A1 (en) 2009-03-19
SI22567A2 (sl) 2008-12-31
JP4966933B2 (ja) 2012-07-04
TR200907629A2 (tr) 2009-11-23
EA200801797A3 (ru) 2009-02-27

Similar Documents

Publication Publication Date Title
DK2086944T3 (da) Fremgangsmåde til fremstilling af difluormethylpyrazolylcarboxylater
DK2046767T3 (da) Fremgangsmåde til fremstilling af diaminophenothiaziniumforbindelser
DK3309139T3 (da) Process for the preparation of 2,3,3,3-trifluoropropene
DK2114886T3 (da) Fremgangsmåde til fremstilling af visse substituerede sulfiliminer
DK2155838T3 (da) Fremgangsmåde til fremstilling af forgrenede carbonhydrider
DK1893586T3 (da) Fremgangsmåde til fremstilling af 1-alkyl-3-phenyluraciler
BRPI0807453A2 (pt) Preparação sólida
PL3354276T3 (pl) Kompozycje do leczenia zapalenia przewodu pokarmowego
BRPI0810482A2 (pt) Métodos de produção de proteína usando compostos antissenescência
DK3216802T3 (da) Produktionsfremgangsmåde
EP2149441A4 (en) VACUUM-ASSISTED RTM METHOD
DK2209900T3 (da) Anvendelse af bakterier til fremstillingen af bioenergi
NO20076030L (no) Fremgangsmåte for fremstilling av hydroklorsilaner
EP1971589A4 (en) PROCESS FOR PREPARING 3-HYDROXYTETRAHYDROFURAN BY MEANS OF CYCLODE HYDROGENATION
DK2125048T3 (da) Præparat
ZA200907191B (en) Process for the preparation of gefitiib
FI20065860A0 (sv) Förfarande för tillverkning av mekanisk massa
FR2897867B1 (fr) Procede de preparation de dimethyl isosorbide
FI20085807A0 (sv) Förfarande för tillverkning av escitalopram
EP2344468A4 (en) PROCESS FOR PREPARING RAMELTÉON
FR2918983B1 (fr) Procede de preparation de dinitrotoluene
DK2151429T3 (da) Fremgangsmåde til fremstilling af agomelatin
FR2947265B1 (fr) Procede de preparation d'alkylalcanolamines
NO20080569L (no) Fremgangsmate for fremstilling av kalsiumforbindelser
DK1912961T3 (da) Fremgangsmåde til fremstilling af bepromolin

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 121570

Country of ref document: FI

MM Patent lapsed